Financials Dr. Soliman Abdel Kader Fakeeh Hospital Company

Equities

4017

SA562GSHUOH7

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. 08:20:05 2024-07-11 am EDT 5-day change 1st Jan Change
58.6 SAR +0.86% Intraday chart for Dr. Soliman Abdel Kader Fakeeh Hospital Company -0.51% 0.00%

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 13,478 - -
Enterprise Value (EV) 1 14,189 14,671 15,006
P/E ratio 48.1 x 37 x 29.2 x
Yield 0.26% 0.4% 0.52%
Capitalization / Revenue 4.83 x 3.99 x 3.37 x
EV / Revenue 5.08 x 4.34 x 3.75 x
EV / EBITDA 25.6 x 21.4 x 17.6 x
EV / FCF -21.8 x -26.9 x -434 x
FCF Yield -4.58% -3.71% -0.23%
Price to Book 6.15 x 5.27 x 4.42 x
Nbr of stocks (in thousands) 230,000 - -
Reference price 2 58.60 58.60 58.60
Announcement Date - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 2,791 3,379 3,997
EBITDA 1 - 554.8 684.3 853.1
EBIT 1 - 381.3 461.8 604.1
Operating Margin - 13.66% 13.66% 15.12%
Earnings before Tax (EBT) 1 - 272 391.7 506
Net income 1 279.6 285.3 369.2 465.6
Net margin - 10.22% 10.92% 11.65%
EPS 2 1.400 1.219 1.583 2.007
Free Cash Flow 1 - -650.1 -544.6 -34.6
FCF margin - -23.29% -16.12% -0.87%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 0.1500 0.2350 0.3050
Announcement Date 4/24/24 - - -
1SAR in Million2SAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - 711 1,193 1,528
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - 1.282 x 1.743 x 1.791 x
Free Cash Flow 1 - -650 -545 -34.6
ROE (net income / shareholders' equity) - 17.5% 15.5% 16.6%
ROA (Net income/ Total Assets) - 5.25% 6% 6.55%
Assets 1 - 5,434 6,153 7,108
Book Value Per Share 2 - 9.520 11.10 13.20
Cash Flow per Share 2 - 1.580 1.220 2.220
Capex 1 - 1,040 977 793
Capex / Sales - 37.25% 28.91% 19.85%
Announcement Date 4/24/24 - - -
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
58.6 SAR
Average target price
64.25 SAR
Spread / Average Target
+9.64%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4017 Stock
  4. Financials Dr. Soliman Abdel Kader Fakeeh Hospital Company